LOS ANGELES, June 18, 2019 (GLOBE NEWSWIRE) -- In an interview with Capital Market Laboratories (CMLviz), chief financial officer of Veeva Systems VEEV Tim Cabral had a clear message: Veeva is changing the game. It's showing that there is a better way to manage clinical data in a trial. The company trades near-term growth for long-term growth, and the company has made that trade-off over the history of its existence to the benefit of shareholders.
Read: One-on-One Interview with Veeva's CFO - Veeva is a Game Changer
Media queries
Alicia Newman, Director Client Services
Capital Market Laboratories
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
